SpinalCyte to Present at China Focus @ Europe Vienna
SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced that Pete OHeeron, SpinalCytes Chief Executive Officer, will present at the China Focus @ Europe Vienna on Wednesday, March 27, 2019 at 3:00 PM CET in Vienna, Austria.
- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced that Pete OHeeron, SpinalCytes Chief Executive Officer, will present at the China Focus @ Europe Vienna on Wednesday, March 27, 2019 at 3:00 PM CET in Vienna, Austria.
- SpinalCyte holds two issued Chinese patents and three Chinese patents pending covering its fibroblast cell therapy technologies.
- Since the recent reform of Chinas drug approval process, clinical trials and new drug approval in China has accelerated.
- The conference will be held on March 27, 2019 at Hilton Vienna Danube Waterfront Vienna, Austria.